During the development of type 1 diabetes, NKG2D receptor expression is increased on NK cells, CD4+ T cells and CD8+ T cells, especially auto-reactive CD8+ T cells, which may play a key role if NKG2D ligand expression is upregulated on pancreatic β cells. Here, CD8A is linked to type 1 diabetes mellitus.